Global Tafenoquine Market Growth 2020-2025


  • Sep 2020
  • |
  • 137
  • |
  • Pharmaceuticals and Healthcare

According to this study, over the next five years the Tafenoquine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Tafenoquine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Tafenoquine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Tafenoquine, covering the supply chain analysis, impact assessment to the Tafenoquine market size growth rate in several scenarios, and the measures to be undertaken by Tafenoquine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Powder

Pills

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Radical Cure of P.vivax

P. falciparum Treatment

Prevention of Malaria Relapse

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

GlaxoSmithKline Pharmaceuticals (GSK)

J & K Scientific LTD

WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.

Pharmacodia (Beijing) Co.,Ltd

BOC Sciences

Amadis Chemical Company Limited

Merck

...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Tafenoquine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Tafenoquine market by identifying its various subsegments.

Focuses on the key global Tafenoquine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Tafenoquine with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Tafenoquine submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tafenoquine Consumption 2015-2025

2.1.2 Tafenoquine Consumption CAGR by Region

2.2 Tafenoquine Segment by Type

2.2.1 Powder

2.2.2 Pills

2.3 Tafenoquine Consumption by Type

2.3.1 Global Tafenoquine Consumption Market Share by Type (2015-2020)

2.3.2 Global Tafenoquine Revenue and Market Share by Type (2015-2020)

2.3.3 Global Tafenoquine Sale Price by Type (2015-2020)

2.4 Tafenoquine Segment by Application

2.4.1 Radical Cure of P.vivax

2.4.2 P. falciparum Treatment

2.4.3 Prevention of Malaria Relapse

2.5 Tafenoquine Consumption by Application

2.5.1 Global Tafenoquine Consumption Market Share by Type (2015-2020)

2.5.2 Global Tafenoquine Value and Market Share by Type (2015-2020)

2.5.3 Global Tafenoquine Sale Price by Type (2015-2020)

3 Global Tafenoquine by Company

3.1 Global Tafenoquine Sales Market Share by Company

3.1.1 Global Tafenoquine Sales by Company (2018-2020)

3.1.2 Global Tafenoquine Sales Market Share by Company (2018-2020)

3.2 Global Tafenoquine Revenue Market Share by Company

3.2.1 Global Tafenoquine Revenue by Company (2018-2020)

3.2.2 Global Tafenoquine Revenue Market Share by Company (2018-2020)

3.3 Global Tafenoquine Sale Price by Company

3.4 Global Tafenoquine Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Tafenoquine Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Tafenoquine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Tafenoquine by Regions

4.1 Tafenoquine by Regions

4.2 Americas Tafenoquine Consumption Growth

4.3 APAC Tafenoquine Consumption Growth

4.4 Europe Tafenoquine Consumption Growth

4.5 Middle East & Africa Tafenoquine Consumption Growth

5 Americas

5.1 Americas Tafenoquine Consumption by Countries

5.1.1 Americas Tafenoquine Consumption by Countries (2015-2020)

5.1.2 Americas Tafenoquine Value by Countries (2015-2020)

5.2 Americas Tafenoquine Consumption by Type

5.3 Americas Tafenoquine Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Tafenoquine Consumption by Regions

6.1.1 APAC Tafenoquine Consumption by Regions (2015-2020)

6.1.2 APAC Tafenoquine Value by Regions (2015-2020)

6.2 APAC Tafenoquine Consumption by Type

6.3 APAC Tafenoquine Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Tafenoquine by Countries

7.1.1 Europe Tafenoquine Consumption by Countries (2015-2020)

7.1.2 Europe Tafenoquine Value by Countries (2015-2020)

7.2 Europe Tafenoquine Consumption by Type

7.3 Europe Tafenoquine Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Tafenoquine by Countries

8.1.1 Middle East & Africa Tafenoquine Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Tafenoquine Value by Countries (2015-2020)

8.2 Middle East & Africa Tafenoquine Consumption by Type

8.3 Middle East & Africa Tafenoquine Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Tafenoquine Distributors

10.3 Tafenoquine Customer

11 Global Tafenoquine Market Forecast

11.1 Global Tafenoquine Consumption Forecast (2021-2025)

11.2 Global Tafenoquine Forecast by Regions

11.2.1 Global Tafenoquine Forecast by Regions (2021-2025)

11.2.2 Global Tafenoquine Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Tafenoquine Forecast by Type

11.8 Global Tafenoquine Forecast by Application

12 Key Players Analysis

12.1 GlaxoSmithKline Pharmaceuticals (GSK)

12.1.1 Company Information

12.1.2 Tafenoquine Product Offered

12.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Latest Developments

12.2 J & K Scientific LTD

12.2.1 Company Information

12.2.2 Tafenoquine Product Offered

12.2.3 J & K Scientific LTD Tafenoquine Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 J & K Scientific LTD Latest Developments

12.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.

12.3.1 Company Information

12.3.2 Tafenoquine Product Offered

12.3.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Latest Developments

12.4 Pharmacodia (Beijing) Co.,Ltd

12.4.1 Company Information

12.4.2 Tafenoquine Product Offered

12.4.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Pharmacodia (Beijing) Co.,Ltd Latest Developments

12.5 BOC Sciences

12.5.1 Company Information

12.5.2 Tafenoquine Product Offered

12.5.3 BOC Sciences Tafenoquine Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 BOC Sciences Latest Developments

12.6 Amadis Chemical Company Limited

12.6.1 Company Information

12.6.2 Tafenoquine Product Offered

12.6.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Amadis Chemical Company Limited Latest Developments

12.7 Merck

12.7.1 Company Information

12.7.2 Tafenoquine Product Offered

12.7.3 Merck Tafenoquine Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Merck Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Tafenoquine Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Powder

Table 5. Major Players of Pills

Table 6. Global Consumption Sales by Type (2015-2020)

Table 7. Global Tafenoquine Consumption Market Share by Type (2015-2020)

Table 8. Global Tafenoquine Revenue by Type (2015-2020) ($ million)

Table 9. Global Tafenoquine Value Market Share by Type (2015-2020) ($ Millions)

Table 10. Global Tafenoquine Sale Price by Type (2015-2020)

Table 11. Global Consumption Sales by Application (2015-2020)

Table 12. Global Tafenoquine Consumption Market Share by Application (2015-2020)

Table 13. Global Tafenoquine Value by Application (2015-2020)

Table 14. Global Tafenoquine Value Market Share by Application (2015-2020)

Table 15. Global Tafenoquine Sale Price by Application (2015-2020)

Table 16. Global Tafenoquine Sales by Company (2017-2019) (Tons)

Table 17. Global Tafenoquine Sales Market Share by Company (2017-2019)

Table 18. Global Tafenoquine Revenue by Company (2017-2019) ($ Millions)

Table 19. Global Tafenoquine Revenue Market Share by Company (2017-2019)

Table 20. Global Tafenoquine Sale Price by Company (2017-2019)

Table 21. Global Tafenoquine Manufacturing Base Distribution and Sales Area by Manufacturers

Table 22. Players Tafenoquine Products Offered

Table 23. Tafenoquine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 24. Global Tafenoquine Consumption by Regions 2015-2020 (Tons)

Table 25. Global Tafenoquine Consumption Market Share by Regions 2015-2020

Table 26. Global Tafenoquine Value by Regions 2015-2020 ($ Millions)

Table 27. Global Tafenoquine Value Market Share by Regions 2015-2020

Table 28. Americas Tafenoquine Consumption by Countries (2015-2020) (Tons)

Table 29. Americas Tafenoquine Consumption Market Share by Countries (2015-2020)

Table 30. Americas Tafenoquine Value by Countries (2015-2020) ($ Millions)

Table 31. Americas Tafenoquine Value Market Share by Countries (2015-2020)

Table 32. Americas Tafenoquine Consumption by Type (2015-2020) (Tons)

Table 33. Americas Tafenoquine Consumption Market Share by Type (2015-2020)

Table 34. Americas Tafenoquine Consumption by Application (2015-2020) (Tons)

Table 35. Americas Tafenoquine Consumption Market Share by Application (2015-2020)

Table 36. APAC Tafenoquine Consumption by Countries (2015-2020) (Tons)

Table 37. APAC Tafenoquine Consumption Market Share by Countries (2015-2020)

Table 38. APAC Tafenoquine Value by Regions (2015-2020) ($ Millions)

Table 39. APAC Tafenoquine Value Market Share by Regions (2015-2020)

Table 40. APAC Tafenoquine Consumption by Type (2015-2020) (Tons)

Table 41. APAC Tafenoquine Consumption Market Share by Type (2015-2020)

Table 42. APAC Tafenoquine Consumption by Application (2015-2020) (Tons)

Table 43. APAC Tafenoquine Consumption Market Share by Application (2015-2020)

Table 44. Europe Tafenoquine Consumption by Countries (2015-2020) (Tons)

Table 45. Europe Tafenoquine Consumption Market Share by Countries (2015-2020)

Table 46. Europe Tafenoquine Value by Countries (2015-2020) ($ Millions)

Table 47. Europe Tafenoquine Value Market Share by Countries (2015-2020)

Table 48. Europe Tafenoquine Consumption by Type (2015-2020) (Tons)

Table 49. Europe Tafenoquine Consumption Market Share by Type (2015-2020)

Table 50. Europe Tafenoquine Consumption by Application (2015-2020) (Tons)

Table 51. Europe Tafenoquine Consumption Market Share by Application (2015-2020)

Table 52. Middle East & Africa Tafenoquine Consumption by Countries (2015-2020) (Tons)

Table 53. Middle East & Africa Tafenoquine Consumption Market Share by Countries (2015-2020)

Table 54. Middle East & Africa Tafenoquine Value by Countries (2015-2020) ($ Millions)

Table 55. Middle East & Africa Tafenoquine Value Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Tafenoquine Consumption by Type (2015-2020) (Tons)

Table 57. Middle East & Africa Tafenoquine Consumption Market Share by Type (2015-2020)

Table 58. Middle East & Africa Tafenoquine Consumption by Application (2015-2020) (Tons)

Table 59. Middle East & Africa Tafenoquine Consumption Market Share by Application (2015-2020)

Table 60. Tafenoquine Distributors List

Table 61. Tafenoquine Customer List

Table 62. Global Tafenoquine Consumption Forecast by Countries (2021-2025) (Tons)

Table 63. Global Tafenoquine Consumption Market Forecast by Regions

Table 64. Global Tafenoquine Value Forecast by Countries (2021-2025) ($ Millions)

Table 65. Global Tafenoquine Value Market Share Forecast by Regions

Table 66. Global Tafenoquine Consumption Forecast by Type (2021-2025) (Tons)

Table 67. Global Tafenoquine Consumption Market Share Forecast by Type (2021-2025)

Table 68. Global Tafenoquine Value Forecast by Type (2021-2025) ($ Millions)

Table 69. Global Tafenoquine Value Market Share Forecast by Type (2021-2025)

Table 70. Global Tafenoquine Consumption Forecast by Application (2021-2025) (Tons)

Table 71. Global Tafenoquine Consumption Market Share Forecast by Application (2021-2025)

Table 72. Global Tafenoquine Value Forecast by Application (2021-2025) ($ Millions)

Table 73. Global Tafenoquine Value Market Share Forecast by Application (2021-2025)

Table 74. GlaxoSmithKline Pharmaceuticals (GSK) Product Offered

Table 75. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (Tons), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2018-2020E)

Table 76. GlaxoSmithKline Pharmaceuticals (GSK) Main Business

Table 77. GlaxoSmithKline Pharmaceuticals (GSK) Latest Developments

Table 78. GlaxoSmithKline Pharmaceuticals (GSK) Basic Information, Company Total Revenue (in $ million), Tafenoquine Manufacturing Base, Sales Area and Its Competitors

Table 79. J & K Scientific LTD Product Offered

Table 80. J & K Scientific LTD Tafenoquine Sales (Tons), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2018-2020E)

Table 81. J & K Scientific LTD Main Business

Table 82. J & K Scientific LTD Latest Developments

Table 83. J & K Scientific LTD Basic Information, Company Total Revenue (in $ million), Tafenoquine Manufacturing Base, Sales Area and Its Competitors

Table 84. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Product Offered

Table 85. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (Tons), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2018-2020E)

Table 86. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Main Business

Table 87. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Latest Developments

Table 88. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Basic Information, Company Total Revenue (in $ million), Tafenoquine Manufacturing Base, Sales Area and Its Competitors

Table 89. Pharmacodia (Beijing) Co.,Ltd Product Offered

Table 90. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (Tons), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2018-2020E)

Table 91. Pharmacodia (Beijing) Co.,Ltd Main Business

Table 92. Pharmacodia (Beijing) Co.,Ltd Latest Developments

Table 93. Pharmacodia (Beijing) Co.,Ltd Basic Information, Company Total Revenue (in $ million), Tafenoquine Manufacturing Base, Sales Area and Its Competitors

Table 94. BOC Sciences Product Offered

Table 95. BOC Sciences Tafenoquine Sales (Tons), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2018-2020E)

Table 96. BOC Sciences Main Business

Table 97. BOC Sciences Latest Developments

Table 98. BOC Sciences Basic Information, Company Total Revenue (in $ million), Tafenoquine Manufacturing Base, Sales Area and Its Competitors

Table 99. Amadis Chemical Company Limited Product Offered

Table 100. Amadis Chemical Company Limited Tafenoquine Sales (Tons), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2018-2020E)

Table 101. Amadis Chemical Company Limited Main Business

Table 102. Amadis Chemical Company Limited Latest Developments

Table 103. Amadis Chemical Company Limited Basic Information, Company Total Revenue (in $ million), Tafenoquine Manufacturing Base, Sales Area and Its Competitors

Table 104. Merck Product Offered

Table 105. Merck Basic Information, Company Total Revenue (in $ million), Tafenoquine Manufacturing Base, Sales Area and Its Competitors

Table 106. Merck Main Business

Table 107. Merck Latest Developments

Table 108. Merck Tafenoquine Sales (Tons), Revenue ($ Million), Price (US$/Gram) and Gross Margin (2018-2020E)

List of Figures

Figure 1. Picture of Tafenoquine

Figure 2. Tafenoquine Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Tafenoquine Consumption Growth Rate 2015-2025 (Tons)

Figure 5. Global Tafenoquine Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Powder

Figure 7. Product Picture of Pills

Figure 8. Global Tafenoquine Consumption Market Share by Type (2015-2020)

Figure 9. Global Tafenoquine Value Market Share by Type (2015-2020)

Figure 10. Tafenoquine Consumed in Radical Cure of P.vivax

Figure 11. Global Tafenoquine Market: Radical Cure of P.vivax (2015-2020) (Tons)

Figure 12. Global Tafenoquine Market: Radical Cure of P.vivax (2015-2020) ($ Millions)

Figure 13. Tafenoquine Consumed in P. falciparum Treatment

Figure 14. Global Tafenoquine Market: P. falciparum Treatment (2015-2020) (Tons)

Figure 15. Global Tafenoquine Market: P. falciparum Treatment (2015-2020) ($ Millions)

Figure 16. Tafenoquine Consumed in Prevention of Malaria Relapse

Figure 17. Global Tafenoquine Market: Prevention of Malaria Relapse (2015-2020) (Tons)

Figure 18. Global Tafenoquine Market: Prevention of Malaria Relapse (2015-2020) ($ Millions)

Figure 19. Global Tafenoquine Consumption Market Share by Application (2015-2020)

Figure 20. Global Tafenoquine Value Market Share by Application (2015-2020)

Figure 21. Global Tafenoquine Sales Market Share by Company in 2017

Figure 22. Global Tafenoquine Sales Market Share by Company in 2019

Figure 23. Global Tafenoquine Revenue Market Share by Company in 2017

Figure 24. Global Tafenoquine Revenue Market Share by Company in 2019

Figure 25. Global Tafenoquine Sale Price by Company in 2019

Figure 26. Global Tafenoquine Consumption Market Share by Regions 2015-2020

Figure 27. Global Tafenoquine Value Market Share by Regions 2015-2020

Figure 28. Americas Tafenoquine Consumption 2015-2020 (Tons)

Figure 29. Americas Tafenoquine Value 2015-2020 ($ Millions)

Figure 30. APAC Tafenoquine Consumption 2015-2020 (Tons)

Figure 31. APAC Tafenoquine Value 2015-2020 ($ Millions)

Figure 32. Europe Tafenoquine Consumption 2015-2020 (Tons)

Figure 33. Europe Tafenoquine Value 2015-2020 ($ Millions)

Figure 34. Middle East & Africa Tafenoquine Consumption 2015-2020 (Tons)

Figure 35. Middle East & Africa Tafenoquine Value 2015-2020 ($ Millions)

Figure 36. Americas Tafenoquine Consumption Market Share by Countries in 2019

Figure 37. Americas Tafenoquine Value Market Share by Countries in 2019

Figure 38. Americas Tafenoquine Consumption Market Share by Type in 2019

Figure 39. Americas Tafenoquine Consumption Market Share by Application in 2019

Figure 40. United States Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 41. United States Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 42. Canada Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 43. Canada Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 44. Mexico Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 45. Mexico Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 46. APAC Tafenoquine Consumption Market Share by Countries in 2019

Figure 47. APAC Tafenoquine Value Market Share by Regions in 2019

Figure 48. APAC Tafenoquine Consumption Market Share by Type in 2019

Figure 49. APAC Tafenoquine Consumption Market Share by Application in 2019

Figure 50. China Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 51. China Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 52. Japan Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 53. Japan Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 54. Korea Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 55. Korea Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 56. Southeast Asia Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 57. Southeast Asia Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 58. India Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 59. India Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 60. Australia Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 61. Australia Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 62. Europe Tafenoquine Consumption Market Share by Countries in 2019

Figure 63. Europe Tafenoquine Value Market Share by Countries in 2019

Figure 64. Europe Tafenoquine Consumption Market Share by Type in 2019

Figure 65. Europe Tafenoquine Consumption Market Share by Application in 2019

Figure 66. Germany Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 67. Germany Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 68. France Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 69. France Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 70. UK Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 71. UK Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 72. Italy Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 73. Italy Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 74. Russia Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 75. Russia Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 76. Middle East & Africa Tafenoquine Consumption Market Share by Countries in 2019

Figure 77. Middle East & Africa Tafenoquine Value Market Share by Countries in 2019

Figure 78. Middle East & Africa Tafenoquine Consumption Market Share by Type in 2019

Figure 79. Middle East & Africa Tafenoquine Consumption Market Share by Application in 2019

Figure 80. Egypt Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 81. Egypt Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 82. South Africa Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 83. South Africa Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 84. Israel Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 85. Israel Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 86. Turkey Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 87. Turkey Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 88. GCC Countries Tafenoquine Consumption Growth 2015-2020 (Tons)

Figure 89. GCC Countries Tafenoquine Value Growth 2015-2020 ($ Millions)

Figure 90. Global Tafenoquine Consumption Growth Rate Forecast (2021-2025) (Tons)

Figure 91. Global Tafenoquine Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 92. Americas Tafenoquine Consumption 2021-2025 (Tons)

Figure 93. Americas Tafenoquine Value 2021-2025 ($ Millions)

Figure 94. APAC Tafenoquine Consumption 2021-2025 (Tons)

Figure 95. APAC Tafenoquine Value 2021-2025 ($ Millions)

Figure 96. Europe Tafenoquine Consumption 2021-2025 (Tons)

Figure 97. Europe Tafenoquine Value 2021-2025 ($ Millions)

Figure 98. Middle East & Africa Tafenoquine Consumption 2021-2025 (Tons)

Figure 99. Middle East & Africa Tafenoquine Value 2021-2025 ($ Millions)

Figure 100. United States Tafenoquine Consumption 2021-2025 (Tons)

Figure 101. United States Tafenoquine Value 2021-2025 ($ Millions)

Figure 102. Canada Tafenoquine Consumption 2021-2025 (Tons)

Figure 103. Canada Tafenoquine Value 2021-2025 ($ Millions)

Figure 104. Mexico Tafenoquine Consumption 2021-2025 (Tons)

Figure 105. Mexico Tafenoquine Value 2021-2025 ($ Millions)

Figure 106. Brazil Tafenoquine Consumption 2021-2025 (Tons)

Figure 107. Brazil Tafenoquine Value 2021-2025 ($ Millions)

Figure 108. China Tafenoquine Consumption 2021-2025 (Tons)

Figure 109. China Tafenoquine Value 2021-2025 ($ Millions)

Figure 110. Japan Tafenoquine Consumption 2021-2025 (Tons)

Figure 111. Japan Tafenoquine Value 2021-2025 ($ Millions)

Figure 112. Korea Tafenoquine Consumption 2021-2025 (Tons)

Figure 113. Korea Tafenoquine Value 2021-2025 ($ Millions)

Figure 114. Southeast Asia Tafenoquine Consumption 2021-2025 (Tons)

Figure 115. Southeast Asia Tafenoquine Value 2021-2025 ($ Millions)

Figure 116. India Tafenoquine Consumption 2021-2025 (Tons)

Figure 117. India Tafenoquine Value 2021-2025 ($ Millions)

Figure 118. Australia Tafenoquine Consumption 2021-2025 (Tons)

Figure 119. Australia Tafenoquine Value 2021-2025 ($ Millions)

Figure 120. Germany Tafenoquine Consumption 2021-2025 (Tons)

Figure 121. Germany Tafenoquine Value 2021-2025 ($ Millions)

Figure 122. France Tafenoquine Consumption 2021-2025 (Tons)

Figure 123. France Tafenoquine Value 2021-2025 ($ Millions)

Figure 124. UK Tafenoquine Consumption 2021-2025 (Tons)

Figure 125. UK Tafenoquine Value 2021-2025 ($ Millions)

Figure 126. Italy Tafenoquine Consumption 2021-2025 (Tons)

Figure 127. Italy Tafenoquine Value 2021-2025 ($ Millions)

Figure 128. Russia Tafenoquine Consumption 2021-2025 (Tons)

Figure 129. Russia Tafenoquine Value 2021-2025 ($ Millions)

Figure 130. Spain Tafenoquine Consumption 2021-2025 (Tons)

Figure 131. Spain Tafenoquine Value 2021-2025 ($ Millions)

Figure 132. Egypt Tafenoquine Consumption 2021-2025 (Tons)

Figure 133. Egypt Tafenoquine Value 2021-2025 ($ Millions)

Figure 134. South Africa Tafenoquine Consumption 2021-2025 (Tons)

Figure 135. South Africa Tafenoquine Value 2021-2025 ($ Millions)

Figure 136. Israel Tafenoquine Consumption 2021-2025 (Tons)

Figure 137. Israel Tafenoquine Value 2021-2025 ($ Millions)

Figure 138. Turkey Tafenoquine Consumption 2021-2025 (Tons)

Figure 139. Turkey Tafenoquine Value 2021-2025 ($ Millions)

Figure 140. GCC Countries Tafenoquine Consumption 2021-2025 (Tons)

Figure 141. GCC Countries Tafenoquine Value 2021-2025 ($ Millions)

Figure 142. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Market Share (2018-2020)

Figure 143. J & K Scientific LTD Tafenoquine Market Share (2018-2020)

Figure 144. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Market Share (2018-2020)

Figure 145. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Market Share (2018-2020)

Figure 146. BOC Sciences Tafenoquine Market Share (2018-2020)

Figure 147. Amadis Chemical Company Limited Tafenoquine Market Share (2018-2020)

Figure 148. Merck Tafenoquine Market Share (2018-2020)

Sample Request is not available